Kyung Nam Pharm Co Ltd (KQ:053950) — Market Cap & Net Worth
Market Cap & Net Worth: Kyung Nam Pharm Co Ltd (053950)
Kyung Nam Pharm Co Ltd (KQ:053950) has a market capitalization of $10.26K (₩15.14 Million) as of July 26, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #31678 globally and #2121 in its home market, demonstrating a 9.39% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Kyung Nam Pharm Co Ltd's stock price ₩1678.00 by its total outstanding shares 9023 (9.02K). See how much does Kyung Nam Pharm Co Ltd reinvest in capital to understand how much of operating cash flow is reinvested back into capital assets.
Kyung Nam Pharm Co Ltd Market Cap History: 2026 to 2026
Kyung Nam Pharm Co Ltd's market capitalization history from 2026 to 2026. Data shows growth from $10.26K to $10.26K (0.00% CAGR).
Kyung Nam Pharm Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Kyung Nam Pharm Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 053950 by Market Capitalization
Companies near Kyung Nam Pharm Co Ltd in the global market cap rankings as of July 26, 2026.
Key companies related to Kyung Nam Pharm Co Ltd by market ranking:
- CEMEX S.A.B. de C.V. (MX:CEMEXCPO): Ranked #31669 globally with a market cap of $11.09K USD ( MX$192.71K MXN).
- Mingzhu Logistics Holdings Ltd (NASDAQ:YGMZ): Ranked #31670 globally with a market cap of $11.06K USD.
- Global UAV Technologies Ltd (STU:YAB2): Ranked #31679 globally with a market cap of $10.13K USD ( €8.66K EUR).
- Bruush Oral Care Inc. (NASDAQ:BRSHF): Ranked #31680 globally with a market cap of $10.10K USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #31669 | CEMEX S.A.B. de C.V. | MX:CEMEXCPO | $11.09K | MX$21.14 |
| #31670 | Mingzhu Logistics Holdings Ltd | NASDAQ:YGMZ | $11.06K | $0.00 |
| #31679 | Global UAV Technologies Ltd | STU:YAB2 | $10.13K | €0.06 |
| #31680 | Bruush Oral Care Inc. | NASDAQ:BRSHF | $10.10K | $0.00 |
Kyung Nam Pharm Co Ltd Historical Marketcap From 2026 to 2026
Between 2026 and today, Kyung Nam Pharm Co Ltd's market cap moved from $10.26K to $ 10.26K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩10.26K | -- |
End of Day Market Cap According to Different Sources
On Jul 25th, 2026 the market cap of Kyung Nam Pharm Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.26K USD |
| MoneyControl | $10.26K USD |
| MarketWatch | $10.26K USD |
| marketcap.company | $10.26K USD |
| Reuters | $10.26K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Kyung Nam Pharm Co Ltd
Kyung Nam Pharm Co.,Ltd. manufactures pharmaceuticals. The company offers over-the-counter products, including antipyretics, analgesics, and antiphlogistics; medications for skin diseases and athlete's foot; pain relief patches/creams, antitussives, mucolytic agents, and expectorants; gastro protective agents/digestives; periodontal/gum disease drugs; medications for liver diseases; ear and nose … Read more